Revolution Medicines, Inc. is 19.8x more valuable than Taysha Gene Therapies, Inc. by market capitalization ($30.74 B vs $1.55 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TSHA | RVMD |
|---|---|---|
| Market cap | $1.55 B | $30.74 B |
| US-listed rank | #2293 | #453 |
| Revenue (latest FY) | $9.77M | $0.00 |
| Net income (latest FY) | -$109.00M | -$1.13B |
| Net margin | -1115.3% | - |
| SEC filings | 386 | 782 |
Revolution Medicines, Inc. is 19.8x more valuable than Taysha Gene Therapies, Inc. by market capitalization ($30.74 B vs $1.55 B).
In their latest fiscal years, Taysha Gene Therapies, Inc. reported $9.77M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Taysha Gene Therapies, Inc. and Revolution Medicines, Inc., or browse the full rankings.